Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alza Considering Viadur Marketing Partner For Late 2000 Launch

Executive Summary

Alza is considering whether to find a marketing partner for Viadur in anticipation of a late 2000/early 2001 launch for the long-acting implant for palliative treatment of advanced prostate cancer.

You may also be interested in...



Pharmacia Trelstar Depot Approval Gives Company Prostate Cancer Therapy

Pharmacia will add a prostate cancer therapy to its oncology products portfolio following approval of Trelstar Depot June 15.

Pharmacia Trelstar Depot Approval Gives Company Prostate Cancer Therapy

Pharmacia will add a prostate cancer therapy to its oncology products portfolio following approval of Trelstar Depot June 15.

Bayer To Market Alza Viadur In U.S.; Weighs International Agreement

Bayer is considering an international marketing arrangement for Alza's Viadur following an agreement to market the long-acting leuprolide acetate implant for prostate cancer in the U.S.

UsernamePublicRestriction

Register

MT142539

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel